ELBW
ELBW
批准号:
7605154
负责人:
DAVID K STEVENSON
金额:
$0.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-15 至 2007-11-30
关键词:
AddressAgeAge-MonthsAreaBehaviorBirth WeightCaringChildhoodCognitiveComputer Retrieval of Information on Scientific Projects DatabaseConflict (Psychology)DatabasesDevelopmentEarly InterventionExtremely Low Birth Weight InfantFamilyFundingGeneric DrugsGrantGrowthHealth PolicyInstitutionLanguageLinkLiteratureMedicalMethodsMorbidity - disease rateMotor SkillsNational Institute of Child Health and Human DevelopmentNeonatalOutcomePopulationPopulation ProgramsPopulation StudyPrevalencePublishingRateResearchResearch PersonnelResourcesServicesSocioeconomic StatusSourceStressUnited States National Institutes of Healthcostfollow-uphandicapping conditioninfancyinfant outcomeintervention programmortalityskills
中文摘要
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目及
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
在过去二十年中,极低出生体重婴儿的死亡率大幅下降。 大量的文献集中在这些婴儿的结果是可用的,但在婴儿期或儿童期的障碍条件的流行率的明确定义尚未公布。 目前,已发表的研究提供了相互矛盾的结果和结论。 由于极低出生体重儿的护理需要大量的资源,因此当讨论成本与效益时,关于极低出生体重儿结局的准确信息是必不可少的。 具体而言,研究目的是:
- 为了跟踪和成功地跟踪18个月大的婴儿,超过80%的婴儿进入新生儿研究网络的通用数据库(GDB),出生体重为401- 1,500克,出生于1993年1月1日之后,
- 通过运动技能、认知技能、语言和行为领域的标准化方法表征研究人群的发育,
- 为了确定极低出生体重婴儿18-22个月(校正年龄)的死亡率和特定医学疾病的患病率,
- 为了表征该人群在18个月时的生长结果及其与神经发育结果的关系,
- 确定这一人口中家庭的社会经济地位及其与发展成果的关系,
- 确定这一人群中的重大家庭压力及其与家庭完整性以及对医疗和发育护理的依从性的关系,
- 评估这一人群对特殊支持服务和早期干预计划的利用情况。 将来自NICHD新生儿研究网络GDB的信息与18个月的随访评估联系起来,为解决卫生政策辩论以及评估护理实践的影响提供了独特的机会。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Mortality rates have decreased dramatically over the past two decades among extremely low birth weight (ELBW) infants. A large volume of literature focused on outcomes of these infants is available, but a clear definition of the prevalence of handicapping conditions during infancy or childhood has yet to be published. Currently, published studies offer conflicting results and conclusions. Accurate information concerning outcome for ELBW infants is essential when cost versus benefit discussions arise because of the tremendous resources utilized in the care of the ELBW infant. Specifically, study objectives are:
- to track and successfully follow at 18 months of age more than 80% of babies entered into the generic database (GDB) of the Neonatal Research Network with birth weights 401-1,500 grams born after January 1, 1993,
- to characterize development of the study population by standardized Methods in the areas of motor skills, cognitive skills, language and behavior,
- to determine the 18-22 month (corrected age) mortality and the prevalence of specific medical morbidities in extremely low birth weight infants,
- to characterize growth outcome and its relationship to neurodevelopmental outcome in this population at 18 months,
- to identify the socio-economic status of families in this population and its relationship to developmental outcome,
- to identify significant family stress in this population and its relationship to family integrity as well as compliance with medical and developmental care,
- to assess the utilization of special support services and early intervention programs by this population. Linking information from the NICHD Neonatal Research Network GDB to a follow-up assessment at 18 months provides a unique opportunity to address health policy debates as well as evaluate the impact of care practices.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chromium Mesoporphyrin in the Prevention of Neonatal Jaundice
-
批准号:7945355
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2009
-
负责人:DAVID K STEVENSON
-
依托单位:
Chromium Mesoporphyrin in the Prevention of Neonatal Jaundice
-
批准号:7778390
-
项目类别:
-
资助金额:$36.24万
-
财政年份:2009
-
负责人:DAVID K STEVENSON
-
依托单位:
Therapeutic Use of Heme Analogs: Absorption in Intestine
-
批准号:7815755
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2009
-
负责人:DAVID K STEVENSON
-
依托单位:
NEUROFIBROMATOSIS SCREENING
-
批准号:7718505
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2008
-
负责人:DAVID K STEVENSON
-
依托单位:
Effects of Statins on Heme Oxygenase-1 Regulation
-
批准号:7210136
-
项目类别:
-
资助金额:$19.78万
-
财政年份:2007
-
负责人:DAVID K STEVENSON
-
依托单位:
CANDIDIASIS
-
批准号:7605206
-
项目类别:
-
资助金额:$2.9万
-
财政年份:2007
-
负责人:DAVID K STEVENSON
-
依托单位:
SURFACTANT POSITIVE AIRWAY PRESSURE AND PULSE OXIMETRY TRIAL IN ELBW INFANTS
-
批准号:7605226
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2007
-
负责人:DAVID K STEVENSON
-
依托单位:
SURFACTANT POSITIVE AIRWAY PRESSURE AND PULSE OXIMETRY TRIAL IN ELBW INFANTS
-
批准号:7717880
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2007
-
负责人:DAVID K STEVENSON
-
依托单位:
NEUROFIBROMATOSIS SCREENING
-
批准号:7604963
-
项目类别:
-
资助金额:$2.63万
-
财政年份:2007
-
负责人:DAVID K STEVENSON
-
依托单位:
Effects of Statins on Heme Oxygenase-1 Regulation
-
批准号:7359601
-
项目类别:
-
资助金额:$23.37万
-
财政年份:2007
-
负责人:DAVID K STEVENSON
-
依托单位:
Effects of Statins on Heme Oxygenase-1 Regulation
-
批准号:7612500
-
项目类别:
-
资助金额:$8.76万
-
财政年份:2007
-
负责人:DAVID K STEVENSON
-
依托单位:
GDB
-
批准号:7605153
-
项目类别:
-
资助金额:$16.06万
-
财政年份:2007
-
负责人:DAVID K STEVENSON
-
依托单位:
SKELETAL PHENOTYPING AND MUTATION SCREENING IN NEUROFIBROMATOSIS
-
批准号:7376453
-
项目类别:
-
资助金额:$0.69万
-
财政年份:2006
-
负责人:DAVID K STEVENSON
-
依托单位:
ELBW
-
批准号:7375182
-
项目类别:
-
资助金额:$2.15万
-
财政年份:2005
-
负责人:DAVID K STEVENSON
-
依托单位:
SURFACTANT POSITIVE AIRWAY PRESSURE AND PULSE OXIMETRY TRIAL IN EXTREMELY LBWI
-
批准号:7375302
-
项目类别:
-
资助金额:$0.53万
-
财政年份:2005
-
负责人:DAVID K STEVENSON
-
依托单位:
GDB
-
批准号:7375181
-
项目类别:
-
资助金额:$18.91万
-
财政年份:2005
-
负责人:DAVID K STEVENSON
-
依托单位:
IMMUNOGENICITY OF HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN VLBW INFANTS
-
批准号:7375272
-
项目类别:
-
资助金额:$0.01万
-
财政年份:2005
-
负责人:DAVID K STEVENSON
-
依托单位:
PHOTO RX
-
批准号:7375231
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2005
-
负责人:DAVID K STEVENSON
-
依托单位:
CANDIDIASIS
-
批准号:7375270
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2005
-
负责人:DAVID K STEVENSON
-
依托单位:
REGISTRY OF MORBIDITY AND MORTALITY AMONG VERY LOW BIRTH WEIGHT INFANTS
-
批准号:7202006
-
项目类别:
-
资助金额:$10.07万
-
财政年份:2004
-
负责人:DAVID K STEVENSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: